ABSOLOGY

PSA

Absoludy PSA Prostate Specific Antigen

· Absoludy PSA is a FIA(Fluorescence immunoassay) based quantitative measuring diagnostic test.
· Measuring the level of PSA to help monitoring on prostate cancer, disease and male hormone.
· PSA is present in small quantities in the serum of men with healthy prostates, but is often elevated in the presence of prostate cancer or other prostate disorders: Prostate cancer is the 1st prevalent & 3rd most deadly cancer for men with newly diagnosed 670K patients per year (worldwide)
· Medical use is Prostate cancer screening, Risk stratification and staging, Post-treatment monitoring and Histology meaning · POC PSA test market portion totaled $68M in 2014 and with annual growth of 3.2% will reach $80M by 2019. · Higher growth in the market will be contingent upon the development of advanced PSA markers.